Zobrazeno 1 - 10
of 466
pro vyhledávání: '"Elisabetta, Bugianesi"'
Autor:
Nuria Perez-Diaz-del-Campo, Gian Paolo Caviglia, Giorgia La Piana, Marta Vernero, Valentina Schillaci, Angelo Armandi, Francesco Stalla, Demis Pitoni, Elisabetta Bugianesi, Alessia Ciancio, Paola Cavalla, Davide Giuseppe Ribaldone
Publikováno v:
Gastrointestinal Disorders, Vol 5, Iss 3, Pp 287-295 (2023)
Being two immune-mediated diseases (IMIDs), the association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) is plausible, but data in the literature are conflicting. The aim of our study was to evaluate the possible association b
Externí odkaz:
https://doaj.org/article/69a6d5a24bf84859901cf9916e8ad910
Autor:
Beatrice Foglia, Salvatore Sutti, Stefania Cannito, Chiara Rosso, Marina Maggiora, Alice Casalino, Claudia Bocca, Erica Novo, Francesca Protopapa, Naresh Naik Ramavath, Alessia Provera, Alessandro Gambella, Elisabetta Bugianesi, Frank Tacke, Emanuele Albano, Maurizio Parola
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD), previously non-alcoholic fatty liver disease (NAFLD), is a leading cause of chronic liver disease worldwide. In 20%–30% of MASLD patients, the disease progresses to metabol
Externí odkaz:
https://doaj.org/article/d6a5de90512a4675bd04fbf010588c35
Autor:
Matthew McTeer, Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M Schattenberg, Elisabetta Bugianesi, Andreas Geier, Manuel Romero Gomez, Jean-Francois Dufour, Mattias Ekstedt, Sven Francque, Hannele Yki-Jarvinen, Michael Allison, Luca Valenti, Luca Miele, Michael Pavlides, Jeremy Cobbold, Georgios Papatheodoridis, Adriaan G Holleboom, Dina Tiniakos, Clifford Brass, Quentin M Anstee, Paolo Missier, LITMUS Consortium investigators
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0299487 (2024)
AimsMetabolic dysfunction Associated Steatotic Liver Disease (MASLD) outcomes such as MASH (metabolic dysfunction associated steatohepatitis), fibrosis and cirrhosis are ordinarily determined by resource-intensive and invasive biopsies. We aim to sho
Externí odkaz:
https://doaj.org/article/67ecf06493dd4d75bdee07628520f62d
Autor:
Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven M. Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramon Bataller, Ulrich Beuers, Jerome Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela E. Castro Narro, Abhijit Chowdhury, Helena Cortez-Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El-Kassas, Samuel Klein, Wayne Eskridge, Jiangao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero-Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia C. Sookoian, C. Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai-Sun Wong, Stavra Xanthakos, Yusuf Yilmaz, Zobair Younossi, Ansley Hobbs, Marcela Villota-Rivas, Philip N. Newsome
Publikováno v:
Annals of Hepatology, Vol 29, Iss 1, Pp 101133- (2024)
The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to determine if content experts and patient advocates were in favor of a chan
Externí odkaz:
https://doaj.org/article/f02c612b79da4aaa8837228f72393227
Autor:
Elisabetta Bretto, Simone Frara, Angelo Armandi, Gian Paolo Caviglia, Giorgio Maria Saracco, Elisabetta Bugianesi, Demis Pitoni, Davide Giuseppe Ribaldone
Publikováno v:
Antibiotics, Vol 13, Iss 3, p 267 (2024)
Helicobacter pylori (H. pylori) infection is a prominent entity within human infectious diseases which cause chronic gastritis, peptic ulcers, gastric malignancies, and extragastric disorders. Its persistent colonization can lead to a systemic inflam
Externí odkaz:
https://doaj.org/article/900d9c82b841482d9b1d3f5decabe278
Autor:
Grazia Pennisi, Marco Enea, Mauro Viganò, Filippo Schepis, Victor de Ledinghen, Annalisa Berzigotti, Vincent Wai-Sun Wong, Anna Ludovica Fracanzani, Giada Sebastiani, Carmen Lara-Romero, Elisabetta Bugianesi, Gianluca Svegliati-Baroni, Fabio Marra, Alessio Aghemo, Luca Valenti, Vincenza Calvaruso, Antonio Colecchia, Gabriele Di Maria, Claudia La Mantia, Huapeng Lin, Yuly P. Mendoza, Nicola Pugliese, Federico Ravaioli, Manuel Romero-Gomez, Dario Saltini, Antonio Craxì, Vito Di Marco, Calogero Cammà, Salvatore Petta
Publikováno v:
JHEP Reports, Vol 5, Iss 9, Pp 100809- (2023)
Background & Aims: We aimed to evaluate the impact of oesophageal varices (OV) and their evolution on the risk of complications of compensated advanced chronic liver disease (cACLD) caused by non-alcoholic fatty liver disease (NAFLD). We also assesse
Externí odkaz:
https://doaj.org/article/9d9deda663e44bcca92288036a0d071b
Autor:
Gian Paolo Caviglia, Aurora Nicolosi, Maria Lorena Abate, Patrizia Carucci, Chiara Rosso, Emanuela Rolle, Angelo Armandi, Serena Aneli, Antonella Olivero, Alessandra Risso, Davide Giuseppe Ribaldone, Christian Fermer, Giorgio Maria Saracco, Silvia Gaia, Elisabetta Bugianesi
Publikováno v:
Current Oncology, Vol 29, Iss 8, Pp 5457-5465 (2022)
Reliable non-invasive biomarkers for the surveillance of patients at risk of hepatocellular carcinoma (HCC) development represent an unmet medical need. Recently, the liver-cancer-specific isoform of serine protease inhibitor Kazal (LC-SPIK) has been
Externí odkaz:
https://doaj.org/article/84cddfdfff51440984cba041be0f58fb
Autor:
Beatrice Foglia, Salvatore Sutti, Stefania Cannito, Chiara Rosso, Marina Maggiora, Riccardo Autelli, Erica Novo, Claudia Bocca, Gianmarco Villano, Naresh Naik Ramavath, Ramy Younes, Ignazia Tusa, Elisabetta Rovida, Patrizia Pontisso, Elisabetta Bugianesi, Emanuele Albano, Maurizio Parola
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 13, Iss 2, Pp 459-482 (2022)
Background & Aims: Hypoxia and hypoxia-inducible factors (HIFs) are involved in chronic liver disease progression. We previously showed that hepatocyte HIF-2α activation contributed significantly to nonalcoholic fatty liver disease progression in ex
Externí odkaz:
https://doaj.org/article/9dd50bbb93b94e6ebc56f2862508dc66
Autor:
Partho Sen, Olivier Govaere, Tim Sinioja, Aidan McGlinchey, Dawei Geng, Vlad Ratziu, Elisabetta Bugianesi, Jörn M. Schattenberg, Antonio Vidal-Puig, Michael Allison, Simon Cockell, Ann K. Daly, Tuulia Hyötyläinen, Quentin M. Anstee, Matej Orešič
Publikováno v:
iScience, Vol 25, Iss 9, Pp 104949- (2022)
Summary: Nonalcoholic fatty liver disease (NAFLD) is an increasingly prevalent disease that is associated with multiple metabolic disturbances, yet the metabolic pathways underlying its progression are poorly understood. Here, we studied metabolic pa
Externí odkaz:
https://doaj.org/article/ff48a05fd4c04ac5b4dbc6cdda589a9f
Autor:
Elisabetta Bretto, Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Giorgio Maria Saracco, Elisabetta Bugianesi, Simone Frara
Publikováno v:
Biomedicines, Vol 11, Iss 8, p 2249 (2023)
Inflammatory bowel disease (IBD) is a term used to represent a group of chronic, relapsing inflammatory disorders of the gastrointestinal tract. Crohn’s disease (CD) and ulcerative colitis (UC) are the two major clinical forms. The global incidence
Externí odkaz:
https://doaj.org/article/096c292a737d4c5fb8cf50242ed2dc4e